1,7-phenanthroline has been researched along with Astrocytoma, Grade IV in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Alvo, S; Bada, L; Castro, J; Diz, M; Durán-Carril, ML; García-Vázquez, JA; Viña, D | 1 |
Chen, T; Lai, H; Li, X; Lin, H; Wang, Y | 1 |
2 other study(ies) available for 1,7-phenanthroline and Astrocytoma, Grade IV
Article | Year |
---|---|
Antitumor activity of copper(II) complexes with Schiff bases derived from N'-tosylbenzene-1,2-diamine.
Topics: 2,2'-Dipyridyl; Antineoplastic Agents; Cisplatin; Coordination Complexes; Copper; Crystallography, X-Ray; Diamines; Glioblastoma; Humans; Ligands; Neuroblastoma; Phenanthrolines; Schiff Bases | 2022 |
Iron(II)-Polypyridyl Complexes Inhibit the Growth of Glioblastoma Tumor and Enhance TRAIL-Induced Cell Apoptosis.
Topics: Animals; Antineoplastic Agents; Apoptosis; Biological Transport; Cell Line, Tumor; Coordination Complexes; Down-Regulation; Extracellular Signal-Regulated MAP Kinases; Ferrous Compounds; Glioblastoma; Humans; Ligands; Male; Matrix Metalloproteinase 9; Mice, Nude; p38 Mitogen-Activated Protein Kinases; Phenanthrolines; Reactive Oxygen Species; Signal Transduction; TNF-Related Apoptosis-Inducing Ligand; Tumor Suppressor Protein p53; Urokinase-Type Plasminogen Activator | 2018 |